Neutralizing antibody responses against LCMV Neutralizing antibody responses against LCMV arise late or not at all (comparable to HIV): Evaluation of affinity maturation and/or of CD8+ T cell mediated immunosuppression specifically also of B cells. Attempt to develop vaccines against LCMV that induce protective antibodies
